PAPERWORK REDUCTION ACT SUBMISSION Please read the instructions before completing this form. For additional forms or assistance in completing this form, contact your agency s Paperwork Clearance Officer. Send two copies of this form, the collection instrument to be reviewed, the Supporting Statement, and any additional documentation to: Office of Information and Regulatory Affairs, Office of Management and Budget, Docket Library, Room 10102, 725 17th Street NW Washington, DC 20503.

1. Agency/ Subagency originating request 2. OMB control number b. None U. S. Environmental Protection Agency, Office of Air and a. 2 0 6 0   0 3 9 3 Radiation 3. Type of information collection ( check one) 4. Type of review requested ( check one)

a. New collection a. X Regular b. Revision of a currently approved collection b. Emergency  Approval requested by: / /

c. X Extension of a currently approved collection c. Delegated d. Reinstatement, without change, of a previously 5. Small entities approved collection for which approval has expired Will this information collection have a significant economic impact on a e. Reinstatement, with change, of a previously substantial number of small entities? X Yes No approved collection for which approval has expired f. Existing collection in use without OMB control 6. Requested expiration date number a. X Three years from approval date For b   f, note Item A2 of Supporting Statement Instructions b. Other Specify: /

7. Title National Volatile Organic Compound Emission Standards for Architectural Coatings 8. Agency form number( s) ( if applicable)

EPA ICR No. 1750.03 9. Keywords Architectural coatings, volatile organic compounds, emission standards 10. Abstract The EPA is regulating architectural coating manufacturers and importers under the Authority of Section 183( e) of the Clean Air Act. The Architectural Coatings rule requires manufacturers and importers of architectural coatings to submit a one time initial notification report, and meet labeling requirements. Optional provisions, such as the recycled coating provision, the tonnage exemption, and the exceedance fee provision, contain additional recordkeeping, reporting and labeling requirements. The EPA will use this information to monitor compliance with the standards.

11. Affected public 12. Obligation to respond ( Mark primary with " P" and all others that apply with " X") ( Mark primary with " P" and all others that apply with " X")

a. Individuals or households d. Farms a. Voluntary b. P Business or other for profit e. Federal Government b. X Required to obtain or retain benefits c. Not for profit institutions f. X State, Local or Tribal c. P Mandatory Government 13. Annual reporting and recordkeeping hour burden 14. Annual reporting and recordkeeping cost burden ( in thousands of dollars)

a. Number of respondents 500 a. Total annualized capital/ startup costs 0 b. Total annual responses 745 b. Total annual costs ( O& M) 0 1. Percentage of these responses c. Total annualized cost requested 0 collected electronically 50 % d. Current OMB inventory 0 c. Total annual hours requested 23,411 e. Difference 0 d. Current OMB inventory 65,851 f. Explanation of difference e. Difference  42,440 1. Program change 0 f. Explanation of difference 2. Adjustment 0 1. Program change 2. Adjustment  42,440 15. Purpose of information collection 16. Frequency of recordkeeping or reporting ( check all that apply)

( Mark primary with " P" and all others that apply with " X") a. X Recordkeeping b. Third party disclosure a. Application for benefits e. Program planning or c. X Reporting b. Program evaluation management 1. X On occasion 2. Weekly c. General purpose statistics f. Research 3. Monthly 4. Quarterly d. Audit g. P Regulatory or compliance 5. Semi annually 6. X Annually compliance 7. Biennially 8. Other 17. Statistical methods NO 18. Agency contact ( person who can best answer questions regarding the Linda Herring, OAQPS, ESD; 919 541 5358 OMB 83 I 10/ 95 19. Certification for Paperwork Reduction Act Submissions On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9.

NOTE: The text of 5 CFR 1320.9, and the related provisions of 5 CFR 1320.8( b)( 3), appear at the end of the instructions. The certification is to be made with reference to those regulatory provisions as set forth in the instructions.

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers: ( a) It is necessary for the proper performance of agency functions; ( b) It avoids unnecessary duplication; ( c) It reduces burden on small entities; ( d) It uses plain, coherent, and unambiguous terminology that is understandable to respondents; ( e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices; ( f) It indicates the retention periods for recordkeeping requirements; ( g) It informs respondents of the information called for under 5 CFR 1320.8( b)( 3): ( i) Why the information is being collected; ( ii) Use of information; ( iii) Burden estimate; ( iv) Nature of response ( voluntary, required for a benefit, or mandatory); ( v) Nature and extent of confidentiality; and ( vi) Need to display currently valid OMB control number; ( h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected ( see note in Item 19 of the instructions); ( i) It uses effective and efficient statistical survey methodology; and ( j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item below and explain the reason in Item 18 of the Supporting Statement.

Signature of Program Office Official Date Signature of Senior Official or designee Oscar Morales, Director Date Collections Strategies Division, Office of Environmental Information Collection OMB 83 I 10/ 95


[Federal Register Volume 86, Number 92 (Friday, May 14, 2021)]
[Notices]
[Page 26528]
[FR Doc No: 2021-10166]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2021-P-0306]

Determination That OVIDE (Malathion) Lotion, 0.5%, Was Not
Withdrawn From Sale for Reasons of Safety or Effectiveness

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) has
determined that OVIDE (malathion) lotion, 0.5%, was not withdrawn from
sale for reasons of safety or effectiveness. This determination means
that FDA will not begin procedures to withdraw approval of abbreviated
new drug applications (ANDAs) that refer to this drug product, and it
will allow FDA to continue to approve ANDAs that refer to the product
as long as they meet relevant legal and regulatory requirements.

FOR FURTHER INFORMATION CONTACT: Kaetochi Okemgbo, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 6272, Silver Spring, MD 20993-0002, 240-
825-9944<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: In 1984, Congress enacted the Drug Price
Competition and Patent Term Restoration Act of 1984 (Pub. L. 98-417)
(the 1984 amendments), which authorized the approval of duplicate
versions of drug products under an ANDA procedure. ANDA applicants
must, with certain exceptions, show that the drug for which they are
seeking approval contains the same active ingredient in the same
strength and dosage form as the ``listed drug,'' which is a version of
the drug that was previously approved. ANDA applicants do not have to
repeat the extensive clinical testing otherwise necessary to gain
approval of a new drug application (NDA).
    The 1984 amendments include what is now section 505(j)(7) of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(j)(7)), which
requires FDA to publish a list of all approved drugs. FDA publishes
this list as part of the ``Approved Drug Products With Therapeutic
Equivalence Evaluations,'' which is known generally as the ``Orange
Book.'' Under FDA regulations, drugs are removed from the list if the
Agency withdraws or suspends approval of the drug's NDA or ANDA for
reasons of safety or effectiveness or if FDA determines that the listed
drug was withdrawn from sale for reasons of safety or effectiveness (21
CFR 314.162).
    A person may petition the Agency to determine, or the Agency may
determine on its own initiative, whether a listed drug was withdrawn
from sale for reasons of safety or effectiveness. This determination
may be made at any time after the drug has been withdrawn from sale,
but must be made prior to approving an ANDA that refers to the listed
drug (Sec.  314.161 (21 CFR 314.161)). FDA may not approve an ANDA that
does not refer to a listed drug.
    OVIDE (malathion) lotion, 0.5%, is the subject of NDA 018613, held
by Taro Pharmaceutical Industries, Ltd., and initially approved on
August 2, 1982. OVIDE is indicated for patients infected with Pediculus
humanus capitis (head lice and their ova) of the scalp hair.
    In a letter dated August 19, 2019, Taro Pharmaceutical Industries
Ltd. notified FDA that OVIDE (malathion) lotion, 0.5%, was being
discontinued, and FDA moved the drug product to the ``Discontinued Drug
Product List'' section of the Orange Book.
    Encube Ethicals Private Ltd. submitted a citizen petition dated
March 19, 2021 (Docket No. FDA-2021-P-0306), under 21 CFR 10.30,
requesting that the Agency determine whether OVIDE (malathion) lotion,
0.5%, was withdrawn from sale for reasons of safety or effectiveness.
    After considering the citizen petition and reviewing Agency records
and based on the information we have at this time, FDA has determined
under Sec.  314.161 that OVIDE (malathion) lotion, 0.5% was not
withdrawn for reasons of safety or effectiveness. The petitioner has
identified no data or other information suggesting that OVIDE
(malathion) lotion, 0.5%, was withdrawn for reasons of safety or
effectiveness. We have carefully reviewed our files for records
concerning the withdrawal of OVIDE (malathion) lotion, 0.5%, from sale.
We have also independently evaluated relevant literature and data for
possible postmarketing adverse events. We have found no information
that would indicate that this drug product was withdrawn from sale for
reasons of safety or effectiveness.
    Accordingly, the Agency will continue to list OVIDE (malathion)
lotion, 0.5%, in the ``Discontinued Drug Product List'' section of the
Orange Book. The ``Discontinued Drug Product List'' delineates, among
other items, drug products that have been discontinued from marketing
for reasons other than safety or effectiveness. FDA will not begin
procedures to withdraw approval of approved ANDAs that refer to this
drug product. Additional ANDAs for this drug product may also be
approved by the Agency as long as they meet all other legal and
regulatory requirements for the approval of ANDAs. If FDA determines
that labeling for this drug product should be revised to meet current
standards, the Agency will advise ANDA applicants to submit such
labeling.

    Dated: May 7, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-10166 Filed 5-13-21; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register: December 29, 2009 (Volume 74, Number 248)]
[Notices]
[Page 68857-68858]
[DOCID:fr29de09-102]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

[Docket No. USCG-2009-1049]

Certificate of Alternative Compliance for the Offshore Supply
Vessel MICHAEL G MCCALL

AGENCY: Coast Guard, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Coast Guard announces that a Certificate of Alternative
Compliance was issued for the offshore supply vessel MICHAEL G MCCALL
as required by 33 U.S.C. 1605(c) and 33 CFR 81.18.

DATES: The Certificate of Alternative Compliance was issued on November
20, 2009.

ADDRESSES: The docket for this notice is available for inspection or
copying at the Docket Management Facility (M-30), U.S. Department of
Transportation, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue, SE., Washington, DC 20590, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal holidays. You may also find this
docket on the Internet by going to http://www.regulations.gov,
inserting USCG-2009-1049 in the ``Keyword'' box, and then clicking
``Search.''

FOR FURTHER INFORMATION CONTACT: If you have questions on this notice,
call CWO2 David Mauldin, District Eight, Prevention Branch, U.S. Coast
Guard, telephone<PHONE_NUMBER>. If you have questions on viewing or
submitting material to the docket, call Renee V. Wright, Program
Manager, Docket Operations, telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Background and Purpose

    The offshore supply vessel MICHAEL G MCCALL will be used for
offshore supply operations. Full compliance with 72 COLREGS and the
Inland Rules Act would hinder the vessel's ability to maneuver within
close proximity of offshore platforms. As a result, the forward
masthead light may be located on the top forward portion of the

pilothouse 21.41' above the hull. Placing the forward masthead light at
the height required by Annex I, paragraph 2(a) of the 72 COLREGS and
Annex I, Section 84.03(a) of the Inland Rules Act would result in a
masthead light location highly susceptible to damage when working in
close proximity to offshore platforms.
    Furthermore, the horizontal distance between the forward and aft
masthead lights may be 11.88'. Placing the aft masthead light at the
horizontal distance from the forward masthead light as required by
Annex I, paragraph 3(a) of the 72 COLREGS and Annex I, Section 84.05(a)
of the Inland Rules Act would result in an aft masthead light location
directly over the aft cargo deck where it would interfere with loading
and unloading operations.
    The Certificate of Alternative Compliance allows for the vertical
placement of the forward masthead light to deviate from requirements
set forth in Annex I, paragraph 2(a) of 72 COLREGS and Annex I, Section
84.03(a) of the Inland Rules Act. In addition, the Certificate of
Alternative Compliance allows for the horizontal separation of the
forward and aft masthead lights to deviate from the requirements of
Annex I, paragraph 3(a) of 72 COLREGS and Annex I, Section 84.05(a) of
the Inland Rules Act.
    This notice is issued under authority of 33 U.S.C. 1605(c), and 33
CFR 81.18.

    Dated: December 1, 2009.
J.W. Johnson,
Commander, U.S. Coast Guard, Chief, Inspections and Investigations
Branch, By Direction of the Commander, Eighth Coast Guard District.
[FR Doc. E9-30934 Filed 12-28-09; 8:45 am]

BILLING CODE 9110-04-P


[Federal Register Volume 86, Number 130 (Monday, July 12, 2021)]
[Notices]
[Pages 36546-36547]
[FR Doc No: 2021-14677]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2021-0409; FRL-8657-01-OCSPP]

Petition To Cancel Seresto Registration; Notice of Availability

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: EPA seeks public comment on a April 8, 2021 petition from the
Center for Biological Diversity (CBD) requesting that the Agency cancel
the registration of insecticide product PNR1427, more commonly known by
its brand name Seresto (EPA Registration No. 11556-155), pursuant to
Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), and
pending such requested cancellation, to suspend Seresto's registration
pursuant to FIFRA. A copy of the petition is available at
regulations.gov in docket ID EPA-HQ-OPP-2021-0409.

DATES: Comments, identified by docket identification (ID) number EPA-
HQ-OPP-2021-0409, must be received on or before September 10, 2021.

ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2021-0409 by one of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be Confidential Business
Information (CBI) or other information whose disclosure is restricted
by statute.
     Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC) (28221T), 1200 Pennsylvania Ave. NW, Washington, DC
20460-0001.
     Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at http://www.epa.gov/dockets/contacts.html.
    Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at http://www.epa.gov/dockets.
    Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, are available at http://www.epa.gov/dockets.
    Due to the public health concerns related to COVID-19, the EPA
Docket Center (EPA/DC) and Reading Room are closed to public visitors
with limited exceptions. The staff continues to provide remote customer
service via email, phone, and webform. For the latest status
information on EPA/DC services and docket access, visit https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Rachel Fletcher, Pesticide Re-
evaluation Division (7508P), Office of Pesticide Programs,
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington,
DC 20460-0001; telephone number:<PHONE_NUMBER>; fax number: (703) 308-
8090; email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    This action is directed to the public in general and may be of
interest to those involved with pesticide manufacture, sale, or use; to
a member or affiliate of a veterinarian interest group, an animal
welfare interest group, an environmental interest group, or a public
health interest group; to federal, state, or local regulatory partners;
or to a member of the general public interested in the manufacture,
sale, or use of pesticides (including pet medications). Given the broad
interest, the Agency has not attempted to identify or describe all the
specific entities that may be affected by this action.
    The following list of North American Industry Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document applies to them.
Potentially affected entities may include:
     Pesticide and Other Agricultural Chemical Manufacturing
(NAICS code 325320).
     Pet and Pet Supplies Stores (NAICS code 453910).
     Pet Care (except Veterinary) Services (NAICS code 812910).
     Veterinarians' medicines merchant wholesalers (NAICS code
424210).
     Veterinary Services (NAICS code 541940).

B. What should I consider as I prepare my comments for EPA?

    1. Submitting CBI. Do not submit this information to EPA through
regulations.gov or email. Clearly mark the part or all of the
information that you claim to be CBI. For CBI information in a disk or
CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as
CBI and then identify electronically within the disk or CD-ROM the
specific information that is claimed as CBI. In addition to the
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.
    2. Tips for preparing your comments. When preparing and submitting
your comments, see the commenting tips at http://www.epa.gov/dockets/comments.html.

C. How can I get copies of this document and other related information?

    A copy of the CBD's Petition, ``Re: Petition to Cancel Registration
of PNR1427 (Brand Name Seresto) under the Federal Insecticide,
Fungicide, and Rodenticide Act; Reg. No. 11556-155'', is available in
the docket under docket identification (ID) number EPA-HQ-OPP-2021-
0409.

II. What does this action do?

    EPA seeks public comment during the next 60 days on a petition
received from the CBD requesting that the Agency cancel the Seresto
registration, and to suspend Seresto's registration pending such
requested cancellation. The petition was submitted under the
Administrative Procedure Act (APA), 5 U.S.C. 553(e). The petition
argues that Seresto must be cancelled because it poses an unreasonable
risk to human health, pets, and the environment. The petition states
that, ``according to a recent aggregate incident summary report, since
this product was introduced in 2012, EPA has received over 75,000
adverse incident reports, including at least 1,698 reports linking the
use of this product to pet deaths and at least 700 involving human
harm.'' CBD asserts that the incidents pose unreasonable adverse
effects under FIFRA, and that ``cancellation of this product is not
only warranted but essential for protecting public health, consumers,
imperiled wildlife, and companion animals.''
    The docket for this action, identified by docket identification
(ID) number EPA-HQ-OPP-2021-0409 is available at http://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), EPA West Bldg., Rm. 3334, 1301 Constitution
Ave. NW, Washington, DC 20460-0001. Please note that due to the public
health emergency the EPA Docket Center (EPA/DC) and Reading Room was
closed to public visitors on March 31, 2020. Our EPA/DC staff will
continue to provide customer service via email, phone, and webform. For
further information on EPA/DC services, docket contact information and
the current status of the EPA/DC and Reading Room, please visit https://www.epa.gov/dockets.

    Authority: 7 U.S.C. 136 et seq.

    Dated: July 6, 2021.
Mary Reaves,
Director, Pesticide Re-Evaluation Division, Office of Pesticide
Programs.
[FR Doc. 2021-14677 Filed 7-9-21; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 83, Number 86 (Thursday, May 3, 2018)]
[Proposed Rules]
[Pages 19495-19497]
[FR Doc No: 2018-09213]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 52

[EPA-R09-OAR-2018-0104; FRL-9977-33-Region 9]

Approval of California Air Plan Revisions, Yolo-Solano Air
Quality Management District

AGENCY: Environmental Protection Agency (EPA).

ACTION: Proposed rule.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) is proposing to
approve a revision to the Yolo-Solano Air Quality Management District
(YSAQMD or ``District'') portion of the California State Implementation
Plan (SIP). This revision concerns emissions of volatile organic
compounds (VOCs) from architectural coatings. We are proposing to
approve a local rule to regulate these emission sources under the Clean
Air Act (CAA or the Act). We are taking comments on this proposal and
plan to follow with a final action.

DATES: Any comments must arrive by June 4, 2018.

ADDRESSES: Submit your comments, identified by Docket ID No. EPA-R09-
OAR-2018-0104 at http://www.regulations.gov, or via email to Arnold
Lazarus, at [email protected]. For comments submitted at
Regulations.gov, follow the online instructions for submitting
comments. Once submitted, comments cannot be removed or edited from
Regulations.gov. For either manner of submission, the EPA may publish
any comment received to its public docket. Do not submit electronically
any information you consider to be Confidential Business Information
(CBI) or other information whose disclosure is restricted by statute.
Multimedia submissions (audio, video, etc.) must be accompanied by a
written comment. The written comment is considered the official comment
and should include discussion of all points you wish to make. The EPA
will generally not consider comments or comment contents located
outside of the primary submission (i.e., on the web, cloud, or other
file sharing system). For additional submission methods, please contact
the person identified in the FOR FURTHER INFORMATION CONTACT section.
For the full EPA public comment policy, information about CBI or
multimedia submissions, and general guidance on making effective
comments, please visit http://www2.epa.gov/dockets/commenting-epa-dockets.

FOR FURTHER INFORMATION CONTACT: Arnold Lazarus, EPA Region IX, (415)
972 3024, [email protected]

SUPPLEMENTARY INFORMATION: Throughout this document, ``we,'' ``us'' and
``our'' refer to the EPA.

Table of Contents

I. The State's Submittal
    A. What rule did the State submit?
    B. Are there other versions of this rule?
    C. What is the purpose of the submitted rule revision?
II. The EPA's Evaluation and Action
    A. How is the EPA evaluating the rule?
    B. Does the rule meet the evaluation criteria?
    C. EPA Recommendations To Further Improve the Rule
    D. Public Comment and Proposed Action
III. Incorporation by Reference
IV. Statutory and Executive Order Reviews

I. The State's Submittal

A. What rule did the State submit?

    Table 1 lists the rule addressed by this proposal with the date
that the revision was adopted by the YSAQMD and the date that it was
submitted by the California Air Resources Board (CARB) to the EPA.

                                             Table 1--Submitted Rule
----------------------------------------------------------------------------------------------------------------
             Local agency                  Rule No.            Rule title             Revised        Submitted
----------------------------------------------------------------------------------------------------------------
YSAQMD................................            2.14  Architectural Coatings..      10/12/2016      01/24/2017
----------------------------------------------------------------------------------------------------------------

    On April 17, 2017, the EPA determined that the submittal for YSAQMD
Rule 2.14 met the completeness criteria in 40 CFR part 51 Appendix V,
which must be met before formal EPA review.

B. Are there other versions of this rule?

    On January 2, 2004 (69 FR 34), the EPA finalized a limited approval
and limited disapproval of a previous submission of Rule 2.14 with no
sanctions because the part of the rule that was disapproved, ``Appendix
A,'' expired by its own terms on January 1, 2005. For additional
information, please see the technical support document (TSD) for
today's rulemaking.

C. What is the purpose of the submitted rule revisions?

    VOCs contribute to the production of ground-level ozone, smog and
particulate matter, which harm human health and the environment.
Section 110(a) of the CAA requires states to submit regulations that
control VOC emissions. Architectural coatings are coatings that are
applied to stationary structures and their accessories. They include
house paints, stains, industrial maintenance coatings, traffic
coatings, and many other products. VOCs are emitted from the coatings
during application and curing, and from the associated solvents used
for thinning and clean-up.
    YSAQMD Rule 2.14 controls VOC emissions from architectural coatings
by establishing VOC limits on architectural coatings supplied, sold,
offered for sale, manufactured, blended, or repackaged for use within
the YSAQMD, as well as architectural coatings applied or solicited for
application within the District. The revisions to Rule 2.14 include the
elimination of the averaging provision, which was the basis for the
EPA's 2004 limited disapproval of a prior version of this rule, and the
tightening of many of the Rule's VOC limits. The TSD has more
information about this rule.

II. The EPA's Evaluation and Action

A. How is the EPA evaluating the rule?

    SIP rules must be enforceable (see CAA section 110(a)(2)), must not
interfere with applicable requirements concerning attainment and
reasonable further progress or other CAA requirements (see CAA section
110(l)), and must not modify certain SIP control requirements in
nonattainment areas without ensuring equivalent or greater emissions
reductions (see CAA section 193).
    Generally, SIP rules must require Reasonably Available Control
Technology (RACT) for each category of sources covered by a Control
Techniques Guidelines (CTG) document, and each major source of VOCs in
ozone nonattainment areas classified as moderate or above (see CAA
section 182(b)(2)). The YSAQMD regulates an ozone nonattainment area
classified as severe nonattainment for the 2008 and the 1997 8-hour
ozone National Ambient Air Quality Standards (40 CFR 81.305).
    Because there is no relevant EPA CTG document and because there are
no major architectural coating sources within the District,
architectural coatings are not subject to RACT requirements. However,
architectural coatings are subject to other VOC content limits and
control measures described in the TSD.
    Guidance and policy documents that we used to evaluate the
enforceability, revision/relaxation, and stringency requirements for
this rule include the following:
    1. ``State Implementation Plans; General Preamble for the
Implementation of Title I of the Clean Air Act Amendments of 1990,''
(57 FR 13498, April 16, 1992 and 57 FR 18070, April 28, 1992).
    2. ``Issues Relating to VOC Regulation Cutpoints, Deficiencies, and
Deviations'' (``the Bluebook,'' U.S. EPA, May 25, 1988; revised January
11, 1990).
    3. ``Guidance Document for Correcting Common VOC & Other Rule
Deficiencies'' (``the Little Bluebook,'' EPA Region 9, August 21,
2001).
    4. National Volatile Organic Compound Emission Standards for
Architectural Coatings, 40 CFR 59, Subpart D.
    5. CARB ``Suggested Control Measure for Architectural Coatings,''
Approved 2007.
    6. YSAQMD Rule 2.14, ``Architectural Coatings,'' EPA Limited
Approval and Limited Disapproval on January 2, 2004 (69 FR 34).

B. Does the rule meet the evaluation criteria?

    This rule is consistent with CAA requirements and relevant guidance
regarding enforceability, stringency, and SIP revisions. The TSD has
more information on our evaluation.

C. EPA Recommendations To Further Improve the Rule

    The TSD describes additional rule revisions that we recommend for
the next time the local agency modifies the rule.

D. Public Comment and Proposed Action

    As authorized in section 110(k)(3) of the Act, the EPA proposes to
fully approve the submitted rule because it fulfills all relevant
requirements. We will accept comments from the public on this proposal
until June 4, 2018. If we take final action to approve the submitted
rule, our final action will incorporate this rule into the federally
enforceable SIP.

III. Incorporation by Reference

    In this rule, the EPA is proposing to include in a final EPA rule
regulatory text that includes incorporation by reference. In accordance
with requirements of 1 CFR 51.5, the EPA is proposing to incorporate by
reference the YSAQMD rule described in Table 1 of this preamble. The
EPA has made, and will continue to make, these materials available
through www.regulations.gov and at the EPA Region IX Office (please
contact the person identified in the FOR FURTHER INFORMATION CONTACT
section of this preamble for more information).

IV. Statutory and Executive Order Reviews

    Under the Clean Air Act, the Administrator is required to approve a
SIP submission that complies with the provisions of the Act and
applicable federal regulations. 42 U.S.C. 7410(k); 40 CFR 52.02(a).
Thus, in reviewing SIP submissions, the EPA's role is to approve state
choices, provided that they meet the criteria of the Clean Air Act.
Accordingly, this proposed action merely proposes to approve state law
as meeting federal requirements and does not impose additional
requirements beyond those imposed by state law. For that reason, this
proposed action:

     Is not a ``significant regulatory action'' subject to
review by the Office of Management and Budget under Executive Orders
12866 (58 FR 51735, October 4, 1993) and 13563 (76 FR 3821, January 21,
2011);
     Is not an Executive Order 13771 (82 FR 9339, February 2,
2017) regulatory action because SIP approvals are exempted under
Executive Order 12866;
     Does not impose an information collection burden under the
provisions of the Paperwork Reduction Act (44 U.S.C. 3501 et seq.);
     Is certified as not having a significant economic impact
on a substantial number of small entities under the Regulatory
Flexibility Act (5 U.S.C. 601 et seq.);
     Does not contain any unfunded mandate or significantly or
uniquely affect small governments, as described in the Unfunded
Mandates Reform Act of 1995 (Pub. L. 104-4);
     Does not have Federalism implications as specified in
Executive Order 13132 (64 FR 43255, August 10, 1999);
     Is not an economically significant regulatory action based
on health or safety risks subject to Executive Order 13045 (62 FR
19885, April 23, 1997);
     Is not a significant regulatory action subject to
Executive Order 13211 (66 FR 28355, May 22, 2001);
     Is not subject to requirements of Section 12(d) of the
National Technology Transfer and Advancement Act of 1995 (15 U.S.C. 272
note) because application of those requirements would be inconsistent
with the Clean Air Act; and
     Does not provide the EPA with the discretionary authority
to address disproportionate human health or environmental effects with
practical, appropriate, and legally permissible methods under Executive
Order 12898 (59 FR 7629, February 16, 1994).
    In addition, the SIP is not approved to apply on any Indian
reservation land or in any other area where the EPA or an Indian tribe
has demonstrated that a tribe has jurisdiction. In those areas of
Indian country, the rule does not have tribal implications and will not
impose substantial direct costs on tribal governments or preempt tribal
law as specified by Executive Order 13175 (65 FR 67249, November 9,
2000).

List of Subjects in 40 CFR Part 52

    Environmental protection, Air pollution control, Incorporation by
reference Intergovernmental relations, Ozone, Particulate matter,
Reporting and recordkeeping requirements, Volatile organic compounds.

    Authority: 42 U.S.C. 7401 et seq.

    Dated: April 18, 2018.
Alexis Strauss,
Acting Regional Administrator, Region IX.
[FR Doc. 2018-09213 Filed 5-2-18; 8:45 am]
BILLING CODE 6560-50-P